González-Lara MF, Córdova-Ramón JC, Gamboa-Domínguez A, Cosme-Labarthe J, Carrillo-Pérez DL

Idioma: Inglés.
Referencias bibliográficas: 6
Paginas: 458-460
Archivo PDF: 147.09 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Bedossa P. Images in hepatology. Telangiectatic adenoma: a variant of hepatocellular adenoma. Ann Hepatol 2004; 3: 163.

2. Hechtman JF, Raoufi M, Fiel MI, Taouli B, Facciuto M, Schiano TD, Blouin AG, et al. Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature. Am J Surg Pathol 2011; 35: 927-32.

3. Stoot JH, Coelen RJ, De Jong MC, Dejong CH. Malignant transformation of hepatocellular adenomas into hepatocel- lular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 2010; 12: 509-22.

4. Deneve JL, Pawlik TM, Cunningham S, Clary B, Reddy S, Scoggins CR, Martin RC, et al. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 2009; 16: 640-8.

5. Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, Bedossa P, et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 2009; 137: 1698-705.

6. Terkivatan T, de Wilt JH, de Man RA, van Rijn RR, Zondervan PE, Tilanus HW, IJzermans JN. Indications and longterm outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 2001; 136: 1033-8.